Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Assets ratio high or low?
The EV/Assets ratio of 4.95x is in line with its estimated 1-year average of 5.04x, around the middle of its estimated 1-year range (4.27x–5.92x).
As of 2026-10-06T19:40:55.868Z.
Calculation as of: 2026-10-06T19:40:55.868Z.
Quote observation: 2026-10-06T19:28:35.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: aba6dde202523e327e8df603f06c84cdc8b0caa676e2570b33753db7f555988b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
4.95x
EV/ASSETS RATIO AVG TTM
N/A
EV/ASSETS RATIO AVG 3Y
N/A
EV/ASSETS RATIO AVG 5Y
N/A
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.58x
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
+213.29%
vs the sector median at left
Market Cap
$11.32M
EV/Assets Ratio
N/A
TTM Avg
0.05x
3Y Avg
0.06x
5Y Avg
0.07x
Market Cap
$11.25M
EV/Assets Ratio
N/A
TTM Avg
0.86x
3Y Avg
0.65x
5Y Avg
1.29x
Market Cap
$11.12M
EV/Assets Ratio
0.18x
TTM Avg
0.17x
3Y Avg
0.79x
5Y Avg
1.27x
Market Cap
$10.92M
EV/Assets Ratio
N/A
TTM Avg
0.20x
3Y Avg
0.73x
5Y Avg
1.52x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caring Brands, Inc. (CABR) | $11.27M | 4.95x | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.32M | N/A | 0.05x | 0.06x | 0.07x |
| Cerenome, Inc. (CNSY)vs › | $11.19M | 0.63x | 1.09x | 1.09x | 1.09x |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.25M | N/A | 0.86x | 0.65x | 1.29x |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 0.18x | 0.17x | 0.79x | 1.27x |
| Pluri Inc. (PLUR)vs › | $11.06M | 1.71x | 1.94x | 1.55x | 1.26x |
| BioVie Inc. (BIVI)vs › | $10.94M | 0.16x | 0.30x | 1.29x | 3.46x |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.92M | N/A | 0.20x | 0.73x | 1.52x |
| Polyrizon Ltd. (PLRZ)vs › | $10.41M | 0.08x | 0.69x | 5.09x | 5.09x |
| Biofrontera Inc. (BFRI)vs › | $11.83M | 0.61x | 0.59x | 0.34x | 0.49x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-10-05 | 4.37x |
| 2026-10-02 | 4.51x |
| 2026-10-01 | 4.65x |
| 2026-09-30 | 4.65x |
| 2026-09-29 | 4.79x |
| 2026-09-28 | 4.89x |
| 2026-09-25 | 4.89x |
| 2026-09-24 | 4.79x |
| 2026-09-23 | 4.93x |
| 2026-09-22 | 5.22x |
| 2026-09-21 | 5.17x |
| 2026-09-18 | 5.64x |
| 2026-09-17 | 5.41x |
| 2026-09-16 | 4.79x |
| 2026-09-15 | 4.60x |
| 2026-09-14 | 4.51x |
| 2026-09-11 | 4.65x |
| 2026-09-10 | 4.42x |
| 2026-09-09 | 4.32x |
| 2026-09-08 | 4.27x |
| 2026-09-04 | 4.98x |
| 2026-09-03 | 5.03x |
| 2026-09-02 | 5.92x |
| 2026-09-01 | 5.41x |
| 2026-08-31 | 5.36x |
| 2026-08-28 | 5.59x |
| 2026-08-27 | 5.55x |
| 2026-08-26 | 5.31x |
| 2026-08-25 | 5.12x |
| 2026-08-24 | 5.41x |
| 2026-08-21 | 5.12x |
| 2026-08-20 | 5.31x |
| 2026-08-19 | 5.59x |
| 2026-08-18 | 5.45x |
| 2026-08-17 | 5.31x |
| 2026-08-14 | 5.55x |
